Expression of hypoxia-inducible factor 1 alpha ameliorate myocardial ischemia in rat

Biochemical and Biophysical Research Communications

Volumn 465, Issue 4, 2015, Pages 691-695

  Jianqiang, Peng ^a   Ping, Zhang ^a   Xinmin, Fan ^a   Zhenhua, Yuan ^b   Ming, Zhou ^a   Ying, Guo ^a  

^a Hunan Provincial People's Hospital   (China)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

Author keywords

Adeno associate virus; Gene therapy; Hypoxia inducible factor 1 alpha; Myocardial ischemia; Rat

Indexed keywords

CD31 ANTIGEN; EVANS BLUE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PARVOVIRUS VECTOR; HIF1A PROTEIN, RAT; RECOMBINANT PROTEIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE SYSTOLIC PRESSURE; HEART SIZE; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VIRUS RECOMBINANT; WISTAR RAT; ANIMAL; CAPILLARY; DEPENDOPARVOVIRUS; DISEASE MODEL; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETICS; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; CAPILLARIES; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; VENTRICULAR REMODELING;

EID: 84941317421     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.08.046     Document Type: Article

References (25)

1. T. Gudbjartsson, K. Andersen, R. Danielsen, A. Geirsson, and G. Thorgeirsson Review on coronary artery disease - part I: epidemiology, pathophysiology, clinical presentation and work-up Laeknabladid 100 12 2014 Dec 667 676
2. D.I. Swerdlow, M.V. Holmes, S. Harrison, and S.E. Humphries The genetics of coronary heart disease Br. Med. Bull. 102 2012 Jun 59 77
3. E.J. Velazquez, and R.O. Bonow Revascularization in severe left ventricular dysfunction J. Am. Coll. Cardiol. 65 6 2015 Feb 17 615 624
4. M.C. Scimia, A.M. Gumpert, and W.J. Koch Cardiovascular gene therapy for myocardial infarction Expert Opin. Biol. Ther. 14 2 2014 Feb 183 195
5. A. Forte, B. Rinaldi, L. Berrino, F. Rossi, U. Galderisi, and M. Cipollaro Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research Clin. Sci. (Lond.) 127 11 2014 Dec 615 634
6. V.F. Panoulas, A. Colombo, A. Margonato, and F. Maisano Hybrid coronary revascularization: promising, but yet to take off J. Am. Coll. Cardiol. 65 1 2015 Jan 6 85 97
7. C.P. Bracken, M.L. Whitelaw, and D.J. Peet The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses Cell Mol. Life Sci. 60 7 2003 Jul 1376 1393
8. G.L. Semenza Hydroxylation of HIF-1: oxygen sensing at the molecular level Physiol. (Bethesda) 19 2004 Aug 176 182
9. G.L. Semenza, and G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol. Cell Biol. 12 12 1992 Dec 5447 5454
10. G.L. Semenza HIF-1: mediator of physiological and pathophysiological responses to hypoxia J. Appl. Physiol. 88 4 2000 Apr 1985 1474 1480
11. A. Loboda, A. Jozkowicz, and J. Dulak HIF-1 and HIF-2 transcription factors-similar but not identical Mol. Cells 29 5 2010 May 435 442
12. T. Eckle, D. Kohler, R. Lehmann, K. El Kasmi, and H.K. Eltzschig Hypoxia-inducible factor-1 is central to cardioprotection: a new paradigm for ischemic preconditioning Circulation 118 2 2008 Jul 8 166 175
13. A.J. Majmundar, W.J. Wong, and M.C. Simon Hypoxia-inducible factors and the response to hypoxic stress Mol. Cell 40 2 2010 Oct 22 294 309
14. M. Kido, L. Du, C.C. Sullivan, X. Li, R. Deutsch, S.W. Jamieson, and et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse J. Am. Coll. Cardiol. 46 11 2005 Dec 6 2116 2124
15. K.G. Shyu, M.T. Wang, B.W. Wang, C.C. Chang, J.G. Leu, P. Kuan, and et al. Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat Cardiovasc Res. 54 3 2002 Jun 576 583
16. B.D. Lichty, C.J. Breitbach, D.F. Stojdl, and J.C. Bell Going viral with cancer immunotherapy Nat. Rev. Cancer 14 8 2014 Aug 559 567
17. D.J. Dismuke, L. Tenenbaum, and R.J. Samulski Biosafety of recombinant adeno-associated virus vectors Curr. Gene Ther. 13 6 2013 Dec 434 452
18. Z. Taimeh, J. Loughran, E.J. Birks, and R. Bolli Vascular endothelial growth factor in heart failure Nat. Rev. Cardiol. 10 9 2013 Sep 519 530
19. X. Xiao, J. Li, and R.J. Samulski Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J. Virol. 72 3 1998 Mar 2224 2232
20. B. Wang, J. Li, F.H. Fu, and X. Xiao Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice J. Orthop. Res. 27 4 2009 Apr 421 426
21. K. Inagaki, S. Fuess, T.A. Storm, G.A. Gibson, C.F. McTiernan, M.A. Kay, and et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8 Mol. Ther. 14 1 2006 Jul 45 53
22. N. Frey, W.M. Franz, K. Gloeckner, M. Degenhardt, M. Muller, O. Muller, and et al. Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias Cardiovasc Res. 47 2 2000 Aug 254 264
23. D. van Vuuren, and A. Lochner Ischaemic postconditioning: from bench to bedside Cardiovasc J. Afr. 19 6 2008 Nov-Dec 311 320
24. R. Bhindi, P.K. Witting, A.C. McMahon, L.M. Khachigian, and H.C. Lowe Rat models of myocardial infarction. Pathogenetic insights and clinical relevance Thromb. Haemost. 96 5 2006 Nov 602 610
25. H. Herweijer, and J.A. Wolff Progress and prospects: naked DNA gene transfer and therapy Gene Ther. 10 6 2003 Mar 453 458